The updates and recommendations by the CDC and several organizations include the addition of the COVID-19 vaccine for pediatric patients and a new pneumococcal conjugate vaccine.
The Advisory Committee on Immunization Practices has released its updates to the annual immunization schedules for 2023 that includes new sections on COVID-19 and polio vaccine recommendations.
The Centers for Disease Control and Prevention (CDC) have released updated recommendations regarding the use of 13-valent pneumococcal conjugate vaccine (PCV13) and 23-valent pneumococcal polysaccharide...
When PCV7 was introduced in pediatric immunization programs, adults experienced a significant decrease in pneumococcal disease. A new study evaluated the more recent introduction of the PCV13 and its impact...
The PPSV23—a long-standing, safe pneumococcal vaccine—and the newer PCV13 have both been recommended for adults aged 65 years and older. In a new study, researchers aimed to compare the safety profiles of...
The 13-valent pneumococcal conjugate vaccine (PCV13) was first introduced in the United States in 2010. However, the effect of PCV13 on pneumococcal meningitis is not currently known.
